Citation Impact
Citing Papers
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
2012 StandoutScience
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
2005 StandoutScience
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation
2003 StandoutNobel
De novo design of self-assembling helical protein filaments
2018 StandoutScienceNobel
Complement Factor H Polymorphism in Age-Related Macular Degeneration
2005 StandoutScience
Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease
2000
The role of innate immunity in atherogenesis
2008
Mechanism of Release and Fate of Excised Oligonucleotides during Nucleotide Excision Repair
2012 StandoutNobel
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003
2005
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Glycosylation: Heterogeneity and the 3D Structure of Proteins
1997
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
2009 StandoutNature
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Role of Complement and Other Innate Immune Mechanisms in the Removal of Apoptotic Cells
2005
Autoimmune Diseases
2001
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Interferon-inducible Ifi200-family genes in systemic lupus erythematosus
2008
Removal of dying cells and systemic lupus erythematosus
2005
The metabolic syndrome
2010 Standout
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Pattern Recognition Receptors and Inflammation
2010 Standout
C-reactive protein: a critical update
2003 Standout
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
2009 StandoutNature
The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development
2000
Features of systemic lupus erythematosus in Dnase1-deficient mice
2000
C-reactive protein: From innocent bystander to pivotal mediator of atherosclerosis
2004
Inefficient Clearance of Dying Cells and Autoreactivity
2006
Toll-Like Receptors and Activation of Autoreactive B Cells
2002
Autophagy in the Pathogenesis of Disease
2008 Standout
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Systemic amyloidosis
2015 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
DNaseI in pathogenesis of systemic lupus erythematosus
2004
Alzheimer’s amyloid fibrils: structure and assembly
2000
Myocardial Reperfusion Injury
2007 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
A blast from the past: clearance of apoptotic cells regulates immune responses
2002
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
2005 StandoutNobel
Genetic dissection of systemic lupus erythematosus
1999
Complement
2001
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
C-Reactive Protein, Inflammation, and Innate Immunity
2001
Nuclear envelope alterations generate an aging‐like epigenetic pattern in mice deficient in Zmpste24 metalloprotease
2010
The Hallmarks of Aging
2013 Standout
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
2005
Points of control in inflammation
2002 StandoutNature
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Susceptibility genes in the pathogenesis of murine lupus.
2002
The HIN-200 family: More than interferon-inducible genes?
2005
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses
2011 StandoutNobel
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Immunologically Active Autoantigens: The Role of Toll-Like Receptors in the Development of Chronic Inflammatory Disease
2007
Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes
2011
Nucleic Acid Recognition by the Innate Immune System
2011
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.
1995
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
2005
Oxidized LDL Receptor LOX-1 Binds to C-Reactive Protein and Mediates Its Vascular Effects
2008
C-Reactive Protein, Insulin Resistance, Central Obesity, and Coronary Heart Disease Risk in Indian Asians From the United Kingdom Compared With European Whites
2001
Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction
2003
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes
2004
C-reactive protein: a critical update
2003 Standout
Nucleosomes Are Exposed at the Cell Surface in Apoptosis
2004
Ultraviolet B Radiation-Induced Cell Death: Critical Role of Ultraviolet Dose in Inflammation and Lupus Autoantigen Redistribution
2003
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
Removal of dying cells and systemic lupus erythematosus
2005
Works of J. Herbert being referenced
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
1999
Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins.
1984
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.
1994
C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction
1999